Advances in leishmaniasis.
By H. Murray, J. Berman, C. Davies, N. Saravia. The Lancet, 2005
1,770 citations recorded by the source corpus.
Subfields: Epidemiology, Parasitology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/f1bf82bdf24d04d3cf3721be556823aac814c259
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Parasitology
Citations in the corpus
- The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and Elimination (2008, background): “guyanensis are the major species that cause new world ZCL [51].”
- Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. (2009, background): “…pyogranulomatous, granulomatous or lymphoplasmacytic inflammations in different tissues (Solano-Gallego et al., 2004; Adamama-Moraitou et al., 2007; Pena et al., 2008; Petanides et al., 2008) and/or lymph node reactive hyperplasia are observed (Mylonakis et al., 2005; Giunchetti et al., 2008).”
- A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a (2013, methodology): “PCR and isoenzyme analysis are available at the CDC for speciation, which may be important for treatment considerations [244] Serology is not useful for cutaneous disease.”
- Antimony in the environment: A review focused on natural waters. III. Microbiota relevant interactions (2007, positive): “This is particularly the case for: (1) studies on toxicity resistance mechanisms conducted in prokaryotic cells such asEscherichia coli and in eukaryotic unicellular microorganisms such as Saccharomyces cerevisiae (baker's yeast) and (2) studies on antimony drugs used to combat protozoan infections ”